Rock Health used data from FDA clearances and approvals from 1997 to 2021 to determine where these devices are used the most.
Here are the AI/machine-learning enabled devices by therapeutic area, the Oct. 8 report found:
1. Radiology: 70 percent
2. Cardiovascular: 12 percent
3. Hematology: 4 percent
4. Neurology: 4 percent
5. Ophthalmic
6. Clinical chemistry
7. General and plastic surgery
8. Microbiology
9. Gastroenterology/urology
10. Anesthesiology
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
